Investors

Webcast ImageWebcast
Ocular Therapeutix, Inc. at Rodman & Renshaw 19th Annual Global Investment Conference (Replay)
09/12/17 at 2:10 p.m. ET
Ocular Therapeutix, Inc. at Rodman & Renshaw 19th Annual Global Investment Conference
Tuesday, September 12, 2017 2:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Ocular Therapeutix, Inc. at Cantor Fitzgerald Global Healthcare Conference (Replay)
09/25/17 at 3:35 p.m. ET
Ocular Therapeutix, Inc. at Cantor Fitzgerald Global Healthcare Conference
Monday, September 25, 2017 3:35 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Founded in 2006, Ocular Therapeutix, Inc. (NASDAQ:OCUL) is focused on the development, commercialization, and manufacturing of innovative ocular therapies using its HYDROME(TM) technology. Our product pipeline candidates utilize our platform to provide differentiated drug delivery solutions that are designed to greatly reduce the complexity and burden of current drop of injection regimens by creating sustained release, one-time or several-month dosage forms. The sustained release of these dru... More >>

Stock QuoteMore >>
OCUL (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$6.37
Change (%) Stock is Down 0.01 (0.16%)
Volume54,779
Data as of 09/25/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
 
Investor EventsMore >>
There are currently no events scheduled.
Industry EventsMore >>
DateTitle
10/20/17
through
10/22/17
OSN New York
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Ocular Therapeutix, Inc. posts new information to the site.
Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.